Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response

Functional-food efficacy cannot be inferred from bioactive-compound content alone. Matrix structure, digestion, microbial and host metabolism, and interindividual variability influence which metabolites reach biological targets. This critical review examined post-ingestion biotransformation as a determinant of functional-food efficacy, integrating evidence identified through PubMed, Scopus, Web of Science, and CENTRAL across four representative pathways—ellagitannin–urolithin, daidzein–equol, dietary fibre–short-chain fatty acids, and glucoraphanin–sulforaphane—with the choline/L-carnitine–TMA/TMAO pathway as a counterexample. Across the pathways reviewed, precursor concentration alone was insufficient to predict functional exposure; conversion efficiency, metabolite identity, food matrix, microbial capacity, exposure kinetics, and host phenotype were recurrent determinants. Direct metabolite delivery improved exposure consistency in pharmacokinetic comparisons, but comparative clinical efficacy remained dependent on pathway, population, formulation, and endpoint. The review’s contribution is to compare precursor-rich, preformed-metabolite, enzyme-assisted, and hybrid strategies within a common sequence linking precursor delivery, conversion, internal exposure, variability, and host response, and to distinguish them according to the type of supporting evidence. Current evidence is limited by heterogeneous designs, variable metabolite quantification, selected populations, and few direct precursor-versus-metabolite comparisons. The strongest technological support applies where conversion can be controlled experimentally, particularly enzyme-assisted glucoraphanin-to-sulforaphane conversion. Evidence for hybrid approaches is pathway-specific: inulin–propionate ester has been tested in human interventions, whereas precursor–metabolite hybrids for urolithins and equol remain conceptual. Post-ingestion biotransformation should therefore be integrated within established bioaccessibility–bioavailability–bioefficacy concepts rather than treated as a new functional-food category.

Authors

Institutions

Publication Details

Journal
Molecules
Published
2026-11-19
DOI
https://doi.org/10.3390/molecules31224212
Primary Topic
Phytochemicals and Antioxidant Activities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response

Armando Echeverría, Luis A. Ramos, Tania María Guzmán-Armenteros
Molecules
Phytochemicals and Antioxidant Activities
article

Post-Ingestion Biotransformation and Functional-Food Bioefficacy: From Food Matrix to Host Response

Armando Echeverría, Luis A. Ramos, Tania María Guzmán-Armenteros
article en

Abstract

Functional-food efficacy cannot be inferred from bioactive-compound content alone. Matrix structure, digestion, microbial and host metabolism, and interindividual variability influence which metabolites reach biological targets. This critical review examined post-ingestion biotransformation as a determinant of functional-food efficacy, integrating evidence identified through PubMed, Scopus, Web of Science, and CENTRAL across four representative pathways—ellagitannin–urolithin, daidzein–equol, dietary fibre–short-chain fatty acids, and glucoraphanin–sulforaphane—with the choline/L-carnitine–TMA/TMAO pathway as a counterexample. Across the pathways reviewed, precursor concentration alone was insufficient to predict functional exposure; conversion efficiency, metabolite identity, food matrix, microbial capacity, exposure kinetics, and host phenotype were recurrent determinants. Direct metabolite delivery improved exposure consistency in pharmacokinetic comparisons, but comparative clinical efficacy remained dependent on pathway, population, formulation, and endpoint. The review’s contribution is to compare precursor-rich, preformed-metabolite, enzyme-assisted, and hybrid strategies within a common sequence linking precursor delivery, conversion, internal exposure, variability, and host response, and to distinguish them according to the type of supporting evidence. Current evidence is limited by heterogeneous designs, variable metabolite quantification, selected populations, and few direct precursor-versus-metabolite comparisons. The strongest technological support applies where conversion can be controlled experimentally, particularly enzyme-assisted glucoraphanin-to-sulforaphane conversion. Evidence for hybrid approaches is pathway-specific: inulin–propionate ester has been tested in human interventions, whereas precursor–metabolite hybrids for urolithins and equol remain conceptual. Post-ingestion biotransformation should therefore be integrated within established bioaccessibility–bioavailability–bioefficacy concepts rather than treated as a new functional-food category.

MoleculesVol. 31(22)
Escuela Superior Politecnica del Litoral (EC), Universidad Católica de Santiago de Guayaquil (EC), Universidad de Las Américas (EC)
Phytochemicals and Antioxidant Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon